Want to discover the best research that’s occurred this year? Editor, Martha Powell, highlights the best of 2018’s infectious diseases research in an A–Z.
Browsing: Disease Diagnosis
Researchers from the Center for Infection and Immunity have made a major breakthrough in diagnoses of pathogenic bacteria with their design, the BacCapSeq platform. It’s the first precision medicine platform to allow simultaneous screening for all known bacterial pathogens, as well as markers for antibiotic resistance and virulence.
During the current opioid crisis, only one-third of youths diagnosed with opioid use disorder were tested for hepatitis C, according to the results of a large national sample presented at IDWeek.
A peek behind the paper – John P. Hays on antibiotic resistance targets for point-of-care diagnostics
In this interview, take a look behind the scenes of a recent Future Microbiology paper on antibiotic resistance targets for point-of-care diagnostics with author, John P. Hays.
Public Health England have confirmed that an individual has been diagnosed with MERS in England
New research indicates that false negative RIAT results could delay antiviral therapy for half of patients admitted to intensive care units.
This week the WHO published its first Essential Diagnostics List, a catalogue of tests for some of the most common conditions and important infectious diseases.
QIAGEN have announced the European launch of their next-generation platform for syndromic insights, QIAstat-Dx®, with data being presented at ECCMID demonstrating early success.
A new study has evaluated a point-of-care diagnostic for syphilis and yaws in the Solomon Islands, where previously only serological tests requiring specialist equipment have been available.
A new study has identified a common pattern of immune response in Ebola-infected monkeys 4 days prior to the development of fever; this response could be utilized as an early diagnosis biomarker.